Global Antibodies Market Size, Share, and COVID-19 Impact Analysis, By Type (Monoclonal Antibodies [mAbs] {Oncology, Autoimmune Diseases, Infectious Diseases}, and Antibody-drug Conjugates [ADCs]), By End-user (Hospitals, and Specialty Centers), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2021 - 2030.
Industry: Healthcare- Introduction
- Objectives of the Study
- Market Definition
- Research Scope
- Research Methodology and Assumptions
- Executive Summary
- Premium Insights
- Porter’s Five Forces Analysis
- Value Chain Analysis
- Top Investment Pockets
- Market Attractiveness Analysis By Type
- Market Attractiveness Analysis By Application
- Market Attractiveness Analysis By Region
- Industry Trends
- Market Dynamics
- Market Evaluation
- Drivers
- Increase demand in therapeutic antibodies
- Restraints
- Inadequate results
- Opportunities
- Rise in Healthcare expenditure
- Challenges
5.5.1. High Cost
- Global Antibody Market Analysis and Projection, By Type
- Segment Overview
- Monoclonal Antibodies
- Antibody-drug Conjugates
- Global Antibody Market Analysis and Projection, By Application
- Segment Overview
- Hospitals
- Specialty Centers
- Global Antibody Market Analysis and Projection, By Regional Analysis
- Segment Overview
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Asia-Pacific
- Japan
- China
- India
- South America
- Brazil
- Middle East and Africa
- UAE
- South Africa
- Global Antibody Market-Competitive Landscape
- Overview
- Market Share of Key Players in the Antibody Market
- Global Company Market Share
- North America Company Market Share
- Europe Company Market Share
- APAC Company Market Share
- Competitive Situations and Trends
- Coverage Launches and Developments
- Partnerships, Collaborations, and Agreements
- Mergers & Acquisitions
- Expansions
- Company Profiles
- Abcam Plc.
- Business Overview
- Company Snapshot
- Company Market Share Analysis
- Company Coverage Portfolio
- Recent Developments
- SWOT Analysis
- Merck KGaA
- Business Overview
- Company Snapshot
- Company Market Share Analysis
- Company Coverage Portfolio
- Recent Developments
- SWOT Analysis
- Thermo Fisher Scientific, Inc.
- Business Overview
- Company Snapshot
- Company Market Share Analysis
- Company Coverage Portfolio
- Recent Developments
- SWOT Analysis
- Cell Signalling Technology, Inc.
- Business Overview
- Company Snapshot
- Company Market Share Analysis
- Company Coverage Portfolio
- Recent Developments
- SWOT Analysis
- Santa Cruz Biotechnology Inc.
- Business Overview
- Company Snapshot
- Company Market Share Analysis
- Company Coverage Portfolio
- Recent Developments
- SWOT Analysis
- PerkinElmer, Inc.
- Business Overview
- Company Snapshot
- Company Market Share Analysis
- Company Coverage Portfolio
- Recent Developments
- SWOT Analysis
- Becton, Dickinson and Company
- Business Overview
- Company Snapshot
- Company Market Share Analysis
- Company Coverage Portfolio
- Recent Developments
- SWOT Analysis
- Bio-Techne Corporation
- Business Overview
- Company Snapshot
- Company Market Share Analysis
- Company Coverage Portfolio
- Recent Developments
- SWOT Analysis
- Proteintech Group, Inc.
- Business Overview
- Company Snapshot
- Company Market Share Analysis
- Company Coverage Portfolio
- Recent Developments
- SWOT Analysis
- Jackson ImmunoResearch Inc.
- Business Overview
- Company Snapshot
- Company Market Share Analysis
- Company Coverage Portfolio
- Recent Developments
- SWOT Analysis
- Abcam Plc.
List of Table
- Global Antibody Market, By Type, 2022-2030(USD Million)
- Global Monoclonal Antibodies, Antibody Market, By Region, 2022-2030(USD Million)
- Global Antibody-drug Conjugates, Antibody Market, By Region, 2022-2030(USD Million)
- Global Antibody Market, By Application, 2022-2030(USD Million)
- Global Hospitals, Antibody Market, By Region, 2022-2030(USD Million)
- Global Specialty Centers, Antibody Market, By Region, 2022-2030(USD Million)
- Global Antibody Market, By Region, 2022-2030(USD Million)
- North America Antibody Market, By Type, 2022-2030(USD Million)
- North America Antibody Market, By Application, 2022-2030(USD Million)
- U.S. Antibody Market, By Type, 2022-2030(USD Million)
- U.S. Antibody Market, By Application, 2022-2030(USD Million)
- Canada Antibody Market, By Type, 2022-2030(USD Million)
- Canada Antibody Market, By Application, 2022-2030(USD Million)
- Mexico Antibody Market, By Type, 2022-2030(USD Million)
- Mexico Antibody Market, By Application, 2022-2030(USD Million)
- Europe Antibody Market, By Type, 2022-2030(USD Million)
- Europe Antibody Market, By Application, 2022-2030(USD Million)
- Germany Antibody Market, By Type, 2022-2030(USD Million)
- Germany Antibody Market, By Application, 2022-2030(USD Million)
- France Antibody Market, By Type, 2022-2030(USD Million)
- France Antibody Market, By Application, 2022-2030(USD Million)
- U.K. Antibody Market, By Type, 2022-2030(USD Million)
- U.K. Antibody Market, By Application, 2022-2030(USD Million)
- Italy Antibody Market, By Type, 2022-2030(USD Million)
- Italy Antibody Market, By Application, 2022-2030(USD Million)
- Spain Antibody Market, By Type, 2022-2030(USD Million)
- Spain Antibody Market, By Application, 2022-2030(USD Million)
- Asia Pacific Antibody Market, By Type, 2022-2030(USD Million)
- Asia Pacific Antibody Market, By Application, 2022-2030(USD Million)
- Japan Antibody Market, By Type, 2022-2030(USD Million)
- Japan Antibody Market, By Application, 2022-2030(USD Million)
- China Antibody Market, By Type, 2022-2030(USD Million)
- China Antibody Market, By Application, 2022-2030(USD Million)
- India Antibody Market, By Type, 2022-2030(USD Million)
- India Antibody Market, By Application, 2022-2030(USD Million)
- South America Antibody Market, By Type, 2022-2030(USD Million)
- South America Antibody Market, By Application, 2022-2030(USD Million)
- Brazil Antibody Market, By Type, 2022-2030(USD Million)
- Brazil Antibody Market, By Application, 2022-2030(USD Million)
- The Middle East and Africa Antibody Market, By Type, 2022-2030(USD Million)
- The Middle East and Africa Antibody Market, By Application, 2022-2030(USD Million)
- UAE Antibody Market, By Type, 2022-2030(USD Million)
- UAE Antibody Market, By Application, 2022-2030(USD Million)
- South Africa Antibody Market, By Type, 2022-2030(USD Million)
- South Africa Antibody Market, By Application, 2022-2030(USD Million)
List of Figures
- Global Antibody Market Segmentation
- Antibody Market: Research Methodology
- Market Size Estimation Methodology: Bottom-Up Approach
- Market Size Estimation Methodology: Top-down Approach
- Data Triangulation
- Porter’s Five Forces Analysis
- Value Chain Analysis
- Top investment pocket in the Antibody Market
- Top Winning Strategies, 2022-2030
- Top Winning Strategies, By Development, 2022-2030(%)
- Top Winning Strategies, By Company, 2022-2030
- Moderate Bargaining power of Buyers
- Moderate Bargaining power of Suppliers
- Moderate Bargaining power of New Entrants
- Low threat of Substitution
- High Competitive Rivalry
- Top Player Positioning, 2022
- Market Share Analysis, 2022
- Restraint and Drivers: Antibody Market
- Antibody Market Segmentation, By Type
- Antibody Market For Monoclonal Antibodies, By Region, 2022-2030 ($ Million)
- Antibody Market For Antibody-drug Conjugates, By Region, 2022-2030 ($ Million)
- Antibody Market Segmentation, By Application
- Antibody Market For Hospitals, By Region, 2022-2030 ($ Million)
- Antibody Market For Specialty Centers, By Region, 2022-2030 ($ Million)
- Abcam Plc.: Net Sales, 2022-2030 ($ Million)
- Abcam Plc.: Revenue Share, By Segment, 2022 (%)
- Abcam Plc.: Revenue Share, By Region, 2022 (%)
- Merck KGaA: Net Sales, 2022-2030 ($ Million)
- Merck KGaA: Revenue Share, By Segment, 2022 (%)
- Merck KGaA: Revenue Share, By Region, 2022 (%)
- Thermo Fisher Scientific, Inc.: Net Sales, 2022-2030 ($ Million)
- Thermo Fisher Scientific, Inc.: Revenue Share, By Segment, 2022 (%)
- Thermo Fisher Scientific, Inc.: Revenue Share, By Region, 2022 (%)
- Cell Signalling Technology, Inc.: Net Sales, 2022-2030 ($ Million)
- Cell Signalling Technology, Inc.: Revenue Share, By Segment, 2022 (%)
- Cell Signalling Technology, Inc.: Revenue Share, By Region, 2022 (%)
- Santa Cruz Biotechnology Inc.: Net Sales, 2022-2030 ($ Million)
- Santa Cruz Biotechnology Inc.: Revenue Share, By Segment, 2022 (%)
- Santa Cruz Biotechnology Inc.: Revenue Share, By Region, 2022 (%)
- PerkinElmer, Inc.: Net Sales, 2022-2030 ($ Million)
- PerkinElmer, Inc.: Revenue Share, By Segment, 2022 (%)
- PerkinElmer, Inc.: Revenue Share, By Region, 2022 (%)
- Becton, Dickinson and Company: Net Sales, 2022-2030 ($ Million)
- Becton, Dickinson and Company: Revenue Share, By Segment, 2022 (%)
- Becton, Dickinson and Company: Revenue Share, By Region, 2022 (%)
- Bio-Techne Corporation: Net Sales, 2022-2030 ($ Million)
- Bio-Techne Corporation: Revenue Share, By Segment, 2022 (%)
- Bio-Techne Corporation: Revenue Share, By Region, 2022 (%)
- Proteintech Group, Inc.: Net Sales, 2022-2030 ($ Million)
- Proteintech Group, Inc.: Revenue Share, By Segment, 2022 (%)
- Proteintech Group, Inc.: Revenue Share, By Region, 2022 (%)
- Jackson Immuno Research Inc.: Net Sales, 2022-2030 ($ Million)
- Jackson Immuno Research Inc.: Revenue Share, By Segment, 2022 (%)
- Jackson Immuno Research Inc.: Revenue Share, By Region, 2022 (%)
Need help to buy this report?
Inquiry Before Buy